Avidity Biosciences, Inc.RNANASDAQ
LOADING
|||
R&D Expense Growth Recovery in Progress
Trending higher, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
58.98%
↓ 23% below average
Average (6y)
76.38%
Historical baseline
Range
High:169.09%
Low:0.00%
Volatility
221.4%
High variability
| Period | Value |
|---|---|
| 2024 | 58.98% |
| 2023 | 26.97% |
| 2022 | 48.65% |
| 2021 | 169.09% |
| 2020 | 158.63% |
| 2019 | 72.34% |
| 2018 | 0.00% |